# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Johannes Huth, pivotal figure in KKR's European ventures, retires after 25 years, leaving legacy of strategic acquisitions ...
MedImpact's bid to reclaim $200 million after acquiring Rite Aid's pharmacy benefits unit has failed. U.S. Bankruptcy J...
UBS analyst Kevin Caliendo maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Neutral and lowers the price target from $...
Barclays analyst Steve Valiquette maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Underweight and lowers the price ta...
Amazon.com Inc. (NASDAQ: AMZN) enhances healthcare accessibility with its RxPass expansion to Medicare beneficiaries, promising...
https://www.barrons.com/articles/nasdaq-100-additions-arm-217b09c8?reflink=desktopwebshare_permalink